Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05016531 · ClinicalTrials.gov registry record · NA
Optimizing Parameters of Low-Intensity Focused Ultrasound for Cortical Modulation in Stroke Patients
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05016531: Completed NA study, sponsored by Duke University.
NCT05016531 is a NA study that has completed, run by Duke University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05016531, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out the optimal intensity and frequency of Low Intensity Focused Ultrasound (LIFU) that is safe and tolerable in people who have had a stroke.
Primary Outcome
A "major response" is pre-defined as having any of the following events: Second degree scalp burn; Clinical seizure; New lesion on DWI sequence of MRI scan and the lesion not explained by any other cause(s) or decreased ADC under the transducer stimulating motor cortex area; Patient discontinues from the study due to any reason.
Interventions
- DEVICE Low Intensity Focused Ultrasonic Stimulation
- DEVICE Low Intensity Focused Ultrasonic Stimulation Frequency
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
What the finished NCT05016531 record still lists
NCT05016531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Intensity Focused Ultrasonic Stimulation is the first listed.
NCT05016531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05016531 about?
NCT05016531 is a clinical study titled "Optimizing Parameters of Low-Intensity Focused Ultrasound for Cortical Modulation in Stroke Patients". The purpose of this research study is to find out the optimal intensity and frequency of Low Intensity Focused Ultrasound (LIFU) that is safe and tolerable in people who have had a stroke.
What is the current status of trial NCT05016531?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-11. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT05016531?
The interventions under investigation include: Low Intensity Focused Ultrasonic Stimulation (DEVICE), Low Intensity Focused Ultrasonic Stimulation Frequency (DEVICE).
Who is sponsoring clinical trial NCT05016531?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05016531's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI